Morgan Stanley Reaffirms “Equal Weight” Rating for Stevanato Group (NYSE:STVN)

Morgan Stanley reiterated their equal weight rating on shares of Stevanato Group (NYSE:STVN) in a research report report published on Monday morning, Benzinga reports. The brokerage currently has a $30.00 price objective on the stock.

STVN has been the topic of a number of other reports. Stephens restated an overweight rating and issued a $38.00 price target on shares of Stevanato Group in a report on Monday, March 25th. BNP Paribas began coverage on shares of Stevanato Group in a report on Monday. They issued an outperform rating on the stock. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the stock has an average rating of Moderate Buy and an average target price of €33.63 ($35.77).

Stevanato Group Trading Up 0.3 %

NYSE STVN opened at €27.31 ($29.05) on Monday. The company has a current ratio of 1.50, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23. Stevanato Group has a 12 month low of €23.00 ($24.47) and a 12 month high of €36.30 ($38.62). The company’s 50-day moving average price is €30.17 and its 200-day moving average price is €29.46. The stock has a market cap of $8.07 billion, a PE ratio of 46.29, a PEG ratio of 2.93 and a beta of 0.70.

Stevanato Group (NYSE:STVN) last issued its earnings results on Thursday, March 7th. The company reported €0.18 ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.19 ($0.20) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 14.31% and a net margin of 13.43%. The business had revenue of €320.60 million for the quarter, compared to the consensus estimate of €326.85 million. During the same quarter in the previous year, the company earned $0.19 earnings per share. The firm’s revenue was up 9.8% on a year-over-year basis. Equities research analysts forecast that Stevanato Group will post 0.67 earnings per share for the current year.

Hedge Funds Weigh In On Stevanato Group

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Fifth Third Bancorp raised its position in shares of Stevanato Group by 23.6% in the 1st quarter. Fifth Third Bancorp now owns 4,956 shares of the company’s stock valued at $159,000 after purchasing an additional 947 shares during the last quarter. Seven Grand Managers LLC purchased a new position in shares of Stevanato Group in the 1st quarter valued at approximately $1,897,000. Raymond James & Associates raised its position in shares of Stevanato Group by 31.5% in the 1st quarter. Raymond James & Associates now owns 270,134 shares of the company’s stock valued at $8,671,000 after purchasing an additional 64,730 shares during the last quarter. Norden Group LLC purchased a new position in shares of Stevanato Group in the 1st quarter valued at approximately $1,028,000. Finally, PNC Financial Services Group Inc. raised its position in Stevanato Group by 54.2% during the 4th quarter. PNC Financial Services Group Inc. now owns 3,089 shares of the company’s stock worth $84,000 after buying an additional 1,086 shares during the last quarter.

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.